Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABRAXANE for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where ABRAXANE was used for Neoplasm malignant.

Most Reported Side Effects for ABRAXANE

Side Effect Reports % Deaths Hosp.
Death 72 23.8% 72 5
Nausea 25 8.3% 14 13
Neutropenia 19 6.3% 13 5
Pancreatic carcinoma 18 5.9% 17 4
Anaemia 17 5.6% 10 5
Fatigue 17 5.6% 10 5
Neuropathy peripheral 14 4.6% 11 2
Alopecia 12 4.0% 6 2
Pneumonia 12 4.0% 8 6
Renal failure 12 4.0% 10 8
Vomiting 12 4.0% 5 7
Constipation 10 3.3% 1 7
Dyspnoea 10 3.3% 3 7
Rash 10 3.3% 4 4
Abdominal pain 9 3.0% 5 9

Other Indications for ABRAXANE

Product used for unknown indication (57) Pancreatic carcinoma (56) Breast cancer (38) Breast cancer metastatic (37) Pancreatic carcinoma metastatic (28) Ovarian cancer (9) Lung neoplasm malignant (8) Squamous cell carcinoma of lung (8) Breast cancer female (7) Gastric cancer (5)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

ABRAXANE Full Profile All Neoplasm malignant Drugs ABRAXANE Demographics ABRAXANE Timeline